Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.
2.
3.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.

Chapman TM, Noble S, Goa KL.

Drugs. 2002;62(13):1945-81. Review. Erratum in: Drugs. 2003;63(5):512..

PMID:
12215068
5.

Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.

Warren E, Weatherley-Jones E, Chilcott J, Beverley C.

Health Technol Assess. 2004 Nov;8(45):iii, 1-57. Review.

6.

Insulin aspart: a review of its use in the management of type 1 or 2 diabetes mellitus.

Reynolds NA, Wagstaff AJ.

Drugs. 2004;64(17):1957-74. Review.

PMID:
15329046
7.

Insulin lispro: a review of its use in the management of diabetes mellitus.

Simpson D, McCormack PL, Keating GM, Lyseng-Williamson KA.

Drugs. 2007;67(3):407-34. Review.

PMID:
17335298
8.

Insulin glargine: a systematic review of a long-acting insulin analogue.

Wang F, Carabino JM, Vergara CM.

Clin Ther. 2003 Jun;25(6):1541-77, discussion 1539-40. Review.

PMID:
12860485
9.

Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

Giugliano D, Ceriello A, Razzoli E, Esposito K.

Clin Drug Investig. 2008;28(4):199-210. Review.

PMID:
18345710
10.

Hypoglycaemia induced by exogenous insulin--'human' and animal insulin compared.

Airey CM, Williams DR, Martin PG, Bennett CM, Spoor PA.

Diabet Med. 2000 Jun;17(6):416-32. Review.

PMID:
10975210
11.
12.

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis.

Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A.

Diabetologia. 2008 Jun;51(6):941-51. doi: 10.1007/s00125-008-0974-3. Epub 2008 Mar 20. Review.

PMID:
18351320
13.
14.

An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.

Pratoomsoot C, Smith HT, Kalsekar A, Boye KS, Arellano J, Valentine WJ.

Diabet Med. 2009 Aug;26(8):803-14. doi: 10.1111/j.1464-5491.2009.02775.x. Review.

15.

[Lispro-insulin analogs in therapy of diabetes].

Rosenberger JS, Eibl N, Schernthaner G.

Wien Klin Wochenschr. 1997 Dec 12;109(23):910-8. Review. German.

PMID:
9487605
16.

Severe hypoglycaemia in type 1 diabetes: impact of the renin-angiotensin system and other risk factors.

Pedersen-Bjergaard U.

Dan Med Bull. 2009 Nov;56(4):193-207. Review.

PMID:
19939337
17.

[Hypoglycemia--a dreaded complication of diabetes].

Bjørgaas M.

Tidsskr Nor Laegeforen. 2000 Aug 30;120(20):2441-4. Review. Norwegian.

PMID:
11475234
19.

Hypoglycaemia in children with type 1 diabetes mellitus.

Chiarelli F, Verrotti A, Catino M, Sabatino G, Pinelli L.

Acta Paediatr Suppl. 1999 Jan;88(427):31-4. Review.

PMID:
10195851
20.

Diabetic hypoglycaemia.

Heller SR.

Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Jul;13(2):279-94. Review.

PMID:
10761867

Supplemental Content

Support Center